David W Haas Selected Research

efavirenz (Sustiva)

1/2022	Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis.
10/2021	Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens.
1/2021	Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine.
1/2020	Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives.
10/2019	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy.
1/2019	Pharmacogenetics and pharmacokinetics of CNS penetration of efavirenz and its metabolites.
1/2018	Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events.
12/2017	Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens.
1/2017	Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.
12/2015	Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David W Haas Research Topics

Disease

47	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 06/2003
15	Infections 10/2019 - 04/2002
10	HIV Infections (HIV Infection) 01/2022 - 08/2003
9	Tuberculosis (Tuberculoses) 01/2022 - 02/2006
6	Hypersensitivity (Allergy) 01/2017 - 08/2005
6	Peripheral Nervous System Diseases (PNS Diseases) 06/2014 - 08/2005
4	Weight Gain 10/2021 - 12/2017
4	Hyperbilirubinemia 09/2015 - 02/2013
3	Mitochondrial Diseases (Mitochondrial Disease) 11/2018 - 07/2006
3	Hemochromatosis (Bronze Diabetes) 11/2018 - 07/2006
3	Coinfection 01/2015 - 09/2007
2	Type 2 Diabetes Mellitus (MODY) 12/2018 - 11/2004
2	Body Weight (Weight, Body) 01/2015 - 11/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2012 - 12/2009
2	Virus Diseases (Viral Diseases) 12/2010 - 01/2010
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2022
1	Frailty 01/2020
1	Hepatitis C 01/2020
1	Cognitive Dysfunction 01/2020
1	Persistent Infection 01/2020
1	Inflammation (Inflammations) 01/2019
1	Disease Progression 01/2019
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2019
1	Disease Susceptibility (Diathesis) 01/2018
1	Drug Hypersensitivity Syndrome 01/2017
1	Jaundice (Icterus) 09/2015
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2014
1	Anemia 12/2013
1	Hyperlactatemia 07/2013
1	Polyneuropathies (Polyneuropathy) 07/2013
1	Hypertriglyceridemia 07/2013

Drug/Important Bio-Agent (IBA)

26	efavirenz (Sustiva)FDA Link 01/2022 - 12/2004
8	Mitochondrial DNA (mtDNA)IBA 01/2021 - 06/2010
8	Atazanavir Sulfate (Reyataz)FDA Link 01/2020 - 11/2004
7	Pharmaceutical PreparationsIBA 01/2022 - 02/2006
6	Tenofovir (Viread)FDA Link 10/2021 - 08/2013
6	abacavir (Ziagen)FDA Link 10/2021 - 08/2005
6	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 10/2021 - 07/2006
6	Ritonavir (Norvir)FDA Link 01/2020 - 11/2004
6	Reverse Transcriptase InhibitorsIBA 10/2019 - 08/2005
6	NucleosidesIBA 06/2010 - 08/2005
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2003
5	Emtricitabine (Emtriva)FDA Link 01/2021 - 08/2013
5	Stavudine (Zerit)FDA LinkGeneric 01/2020 - 09/2005
5	Lamivudine (Epivir)FDA Link 01/2019 - 08/2006
5	RNA (Ribonucleic Acid)IBA 01/2019 - 06/2003
5	Nevirapine (Viramune)FDA Link 01/2017 - 08/2005
4	Didanosine (Videx)FDA LinkGeneric 01/2020 - 08/2006
4	Zidovudine (Retrovir)FDA LinkGeneric 06/2014 - 08/2006
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 09/2007
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 12/2013
3	IntegrasesIBA 10/2021 - 12/2017
3	dolutegravirIBA 01/2021 - 12/2017
3	IronIBA 11/2018 - 07/2006
3	Lopinavir FDA Link 08/2013 - 11/2004
3	Cytochrome P-450 CYP3AIBA 04/2013 - 09/2007
3	Oxidants (Oxidizing Agents)IBA 05/2009 - 12/2003
3	Nelfinavir (Viracept)FDA Link 03/2008 - 12/2005
2	bedaquiline (R207910)IBA 12/2022 - 04/2012
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022 - 01/2021
2	rifapentine (Priftin)FDA Link 01/2021 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 03/2013
2	Peptides (Polypeptides)IBA 01/2017 - 12/2010
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017 - 12/2010
2	BilirubinIBA 09/2015 - 04/2014
2	Darunavir (Prezista)FDA Link 10/2014 - 01/2013
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2009 - 10/2003
1	Clofazimine (Lamprene)FDA Link 12/2022
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2022
1	GoldIBA 11/2021
1	Tuberculin (PPD)IBA 11/2021
1	Integrase InhibitorsIBA 10/2021
1	tenofovir alafenamideIBA 01/2021
1	theasinensin AIBA 01/2021
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 01/2020
1	etonogestrel (Implanon)FDA Link 01/2020
1	Long Noncoding RNAIBA 01/2019
1	CCR5 Receptors (CCR5 Receptor)IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	lamivudine drug combination abacavir FDA Link 12/2017
1	RacivirIBA 12/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	Biological ProductsIBA 01/2016
1	CreatinineIBA 09/2015
1	RifamycinsIBA 01/2015
1	Dihydrotachysterol (AT 10)IBA 01/2015
1	Raltegravir Potassium FDA Link 10/2014
1	Fibroblast Growth Factor 7 FDA Link 08/2014
1	HLA-B57 antigenIBA 01/2014
1	CholesterolIBA 07/2013
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2013
1	Pregnane X ReceptorIBA 04/2013

Therapy/Procedure

29	Therapeutics 01/2022 - 08/2003
14	Art Therapy 01/2021 - 03/2008
2	Aftercare (After-Treatment) 12/2018 - 02/2006
1	Intramuscular Injections 01/2022
1	Female Contraceptive Devices (Vaginal Ring) 01/2020
1	Duration of Therapy 01/2015
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2014
1	Intravenous Administration 08/2014